AstraZeneca in $560 m deal for respiratory firm

There are 1 comment on the Seattle Times story from Jun 10, 2013, titled AstraZeneca in $560 m deal for respiratory firm. In it, Seattle Times reports that:

British drugmaker AstraZeneca PLC says it is to acquire Pearl Therapeutics Inc., a Redwood-City, California-based company involved in therapies for asthma and chronic obstructive pulmonary disease for at least $560 million.

Join the discussion below, or Read more at Seattle Times.

Since: Apr 13

Location hidden

#1 Jun 10, 2013
This sounds promising.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Biotech Discussions

Title Updated Last By Comments
News Oyez! Town Crier at Royal Baby Birth Captures A... 8 hr Anita Bryant s Jihad 1
News Some beards are crappy because they are 11 hr geri 1
News A3 adenosine receptor can activate 'off signals... Apr 25 bobb 1
News Bashful? Buy the little blue pill online (May '13) Apr 19 brianfarrel 13
News FHA Mortgage Focus Fuels Lend America's Rise (Jan '09) Apr 17 Now worried 834
News Viagra may work for women, too (Jul '08) Apr 16 Xase34 26
News Genetically Modified Crops May Yield Less Food,... Apr 16 Bob 1
More from around the web